Michael Teufel

2PUBLICATIONS
29CO-AUTHORS
Molecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 10, 2026
Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial.

|Jun 03, 2023
The MDM2-p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study.

Patricia LoRusso, Noboru Yamamoto, Manish R Patel

Pageof 1

Frequent Collaborators

2 joint publications

Patricia LoRusso

2 joint publications

Mehdi Lahmar

1 joint publications

Noboru Yamamoto

1 joint publications

Manish R Patel